Article
Dolutegravir Inhibits Proliferation and Motility of BT-20 Tumor Cells through Inhibition of Human Endogenous Retrovirus Type K
2022-02-18
Abstract excerpt
Increasing evidence points to the role of endogenous retroviruses (ERVs) in driving cancer cell proliferation. The purpose of this study was to explore the possibility of repurposing antiretroviral agents to inhibit ERVs as a new approach in cancer treatment. We found that an integrase strand-transfer inhibitor, dolutegravir (DTG), effectively inhibited the proliferation of multiple cancer cell lines and its antip...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ba055688-deab-5b18-9963-434e586ad94d
- DOI
- 10.20944/preprints202202.0223.v1
